Inspect an author's raw data, methods, and reproducibility across their publications.
Press Enter ↵ to find
Fuel Your Discoveries
"The greatest challenge to any thinker is stating the problem in a way that will allow a solution."
- Bertrand Russell
Quick Explanation
Copied
Nawei Sun — scientific readout (BGPT)
Evidence from a detailed method paper (ME-Scan) shows high technical leverage in detecting polymorphic mobile element insertions with explicit sensitivity/support metrics and an openly described computational pipeline (). Across published work highlighted in OpenAlex, the research themes strongly cluster around neurodevelopmental disorder genetics and systems biology (e.g., Tourette/ASD gene discovery and downstream pathway convergence), but this review is limited by the absence of full-text excerpts for most cited titles in the provided dataset.
Long Explanation
Author Review — Nawei Sun
April 08, 2026 • Evidence-based • Skeptical • Inline citations
1) Visual evidence from the provided raw-data-enabled paper
The strongest “data-backed” component in your provided materials is the Mobile DNA (2020) paper on Integrated Mobile Element Scanning (ME-Scan), including explicit locus counts, polymorphic/novel fractions, and sensitivity estimates.
ME family candidate counts (provided extraction)
Candidate loci across 36 individuals for AluYb, L1HS, and SVA; further split into polymorphic vs novel categories, as extracted from the provided study summary.
ME family sensitivity (as reported)
Study reports average individual sensitivity for fixed reference MEIs and claims for pooled sensitivity.
Somatic candidate validation signal (from provided extraction)
The extracted summary indicates somatic MEI candidates were rare and that validation largely failed for SVA somatic candidates.
2) Scientific strengths inferred from the provided content
2.1 Method development with measurable performance claims
The ME-Scan paper is unusually transparent about performance proxies (locus support metrics such as TPM/UR as stated in the provided extraction), explicit candidate counts, and sensitivity estimates for fixed reference MEIs.
2.2 Falsifiability and blindspot-aware limitations (as extracted)
The extraction explicitly notes short-read/repeat mapping limits (and potential exclusion of multi-mappers), transduction/5′ truncation effects, primer-family bias, and the difficulty of somatic MEI detection.
The extraction includes a concrete SRA project identifier and a public GitHub repository for the pipeline.
3) Evidence-based critique (where the provided dataset is strong vs weak)
3.1 What we can judge rigorously from the provided materials
Strongly supported: performance reporting, candidate/polymorphic/novel breakdown, and explicit limitations for MEI detection are directly present in the extracted summary of the ME-Scan paper.
Weakly supported: most other papers listed for the author cannot be rigorously critiqued here because the prompt provides only titles/DOIs/metadata for many entries, not the full text excerpts or raw-data extracts.
3.2 Likely general methodological pattern (but not fully auditable here)
The author’s publication themes (from the provided titles) appear to span: neurodevelopmental disorder genetics (ASD/Tourette/ADHD), large-effect rare variants, and mechanistic follow-through via cellular/protein interaction or functional convergence. However, without full-text excerpting for each item, claims about experimental designs (e.g., sample ascertainment bias, functional assay validation strength, replication) would be speculative—so this review does not overreach beyond the ME-Scan paper’s explicit extracted evidence.
Below are additional DOIs present in the provided OpenAlex-like dataset. Here, I only use them to anchor topic scope (not to infer methods/results details) because detailed excerpts were not provided in the prompt.
5) What would most improve this author review (BGPT actionable)
To rigorously critique author-level scientific strength across the author’s broader portfolio, BGPT would need full-text extracts (or at least structured metadata + result numbers + validation details) for each key paper, especially:
Sample ascertainment design + QC metrics for any human genetic cohort studies.
How “large-effect” genes were defined (thresholding, priors, replication) and whether results were pre-registered.
Functional follow-up: assay types, effect directionality, number of independent experimental replicates, and negative/failed validation reporting.
Any claims about cellular convergence: statistical integration methods and robustness checks.
Without these, the only fully auditable rigor claims in this response are those grounded in the extracted ME-Scan evidence.
None—no user command or dataset requiring new computation was provided; only extracted counts/sensitivity were available for visualization.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Strongman: “X-linked male risk is purely biological and not confounded by ascertainment.” This could be wrong if ascertainment/phenotyping differences by sex materially shift observed burden; the prompt excerpting is insufficient to validate that claim here.
Strongman: “Somatic MEIs are common in bulk brain and should be reliably detectable with targeted short-read methods.” This is undermined by the extracted ME-Scan note that somatic candidate validation was largely unsuccessful under their setup.
novel_experiments…
novel_experiments…
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Fuel Your Discoveries
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Discussion